Evaluation of Regulatory T-Cells (Tregs) in Benign Prostatic Pathologies: A Pilot Study
- 8 February 2021
- journal article
- research article
- Published by Kahramanmaras Sutcu Imam Universitesi Tip Fakultesi Dergisi in Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi
- Vol. 16 (1) , 1-6
Abstract
Objective: We aimed to evaluate the number and function of regulatory T (Treg) cells in peripheral blood and prostate tissues of patients with histopathologically diagnosed benign prostate hyperplasia (BPH) and asymptomatic chronic prostatitis. Material and Methods: Blood and histopathological data of 19 patients (BPH=10, ACP=9) that underwent transurethral prostate resection were evaluated. Treg cell count in peripheral blood and prostatic tissue with flowcytometry, Forkhead box P3 (FOXP3) expression in prostatic tissue by reverse transcription polymerase chain reaction (PCR), and IL-17 measurement in blood samples with ELISA were performed. Results: Flowcytometric analyses showed that mean CD4+T cell count and mean FOXP3 levels in both peripheral blood (CD4+T, p= 0.752; FOXP3, p= 1.000) and prostate tissue (CD4+T, p= 0.458; FOXP3, p= 0.590) were higher in the BPH group compared to the chronic prostatitis group. However this difference was not statistically significant. Similarly, the mean blood IL-17 levels were also higher in BPH groups, but the difference was not statistically significant (p= 0.870). The PCR analyses showed that mean FOXP3 gene expression in the tissue was higher in the chronic prostate group, but again there was no statistically significant difference between the groups (p= 0.116). Conclusion: Since no statistically significant difference was found between BPH and chronic prostatitis in terms of Treg cell number and function in peripheral blood and prostatic tissue, our study supports the thesis that both these pathologies could be autoimmune inflammatory diseases.Keywords
This publication has 27 references indexed in Scilit:
- Regulatory T Cells in Renal Transplantation and Modulation by ImmunosuppressionTransplantation, 2009
- How Diverse--CD4 Effector T Cells and their FunctionsJournal of Molecular Cell Biology, 2009
- Mechanisms of Foxp3+ T Regulatory Cell-Mediated SuppressionImmunity, 2009
- Evaluation of Prostatitis in Autopsied Prostates—Is Chronic Inflammation More Associated With Benign Prostatic Hyperplasia or Cancer?Journal of Urology, 2008
- Chronic inflammation in benign prostatic hyperplasia: Implications for therapyMedical Hypotheses, 2008
- Examination of the Relationship Between Symptoms of Prostatitis and Histological Inflammation: Baseline Data From the REDUCE Chemoprevention TrialJournal of Urology, 2007
- Inflammation in prostate carcinogenesisNature Reviews Cancer, 2007
- Expanding the effector CD4 T-cell repertoire: the Th17 lineageCurrent Opinion in Immunology, 2006
- Intraepithelial and stromal lymphocytes in the normal human prostateThe Prostate, 2003
- PSA is a candidate self-antigen in autoimmune chronic prostatitis/chronic pelvic pain syndromeThe Prostate, 2000